newest glp-1 medications for type 2 diabetes 2025 In the phase 3 ACHIEVE-1 trial, published in June 2025, the oral small-molecule receptor agonist orforglipron significantly reduced the glycated hemoglobin level over a period of 40 weeks in adults with Use of glucose-lowering medications in

Glutathione pills are also gaining popularity in Sub-Saharan African countries where hyperpigmentation is a common skin problem

But constipation in certain instances, in rare instances, I mean, it can lead to obstruction and perforations

Maternal choline concentrations during pregnancy and choline-related genetic variants as risk factors for neural tube defects

Methylcobalamin B12 is available in-clinic in Arcadia or Beverly Hills and through mobile injection service across Los Angeles County

Disuse-induced muscle fibrosis, cellular senescence, and senescence-associated secretory phenotype in older adults are alleviated during re-ambulation with metformin pre-treatment